Edwin E Mohler, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 229 S Hemlock Ln, Williamstown, MA 01267 Phone: 518-869-6666 |
News Archive
The U.S. Food and Drug Administration today approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women.
The study reports on two professional painters, both of whom had a stroke, located in the left occipital lobe of the brain and limbic thalamus, respectively.
Reporting for Kaiser Health News, Maggie Mertens writes: "State regulators are cracking down on a health care product that targets the growing group of uninsured and underinsured Americans: the discount health plan" (Mertens, 4/29).
Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. Those hard-to-treat diseases include malaria, tuberculosis, dengue fever, and other conditions. That's the topic of the cover story scheduled for the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.
HSE University researchers have become the first in the world to discover genetic predisposition to severe COVID-19. The results of the study were published in the journal Frontiers in Immunology.
› Verified 9 days ago